Abstract
Ossabaw miniature swine were fed an excess calorie, atherogenic diet for 6, 9, or 12 months. Increased body weight, hypertension, and increased plasma cholesterol and triglycerides are described in Table 1. For more detailed interpretations and conclusions about the data, see our associated research study, “Biphasic alterations in coronary smooth muscle Ca2+ regulation during coronary artery disease progression in metabolic syndrome” McKenney-Drake, et al. (2016) [1].
Specification Table
Subject area | Physiology |
More specific subject area | Metabolic syndrome development |
Type of data | Table |
How data was acquired | Plasma biochemical analysis |
Data format | Analyzed |
Experimental factors | Metabolic syndrome was induced by atherogenic diet feeding for 6, 9, and 12 months. |
Experimental features | Repeat cross sectional study of metabolic syndrome induction at different time points of atherogenic diet feeding. |
Data source location | Indianapolis, IN, United States of America. |
Data accessibility | With this article |
Value of the data
-
•
These data could assist researchers in study design for induction of metabolic syndrome.
-
•
Provide previously unreported time-dependent aspects of metabolic syndrome.
-
•
May provide insight toward development of therapies at different time points of metabolic syndrome progression.
1. Data
Here, we conducted a repeat cross-sectional analysis of metabolic syndrome development in Ossabaw swine during atherogenic diet feeding for 6, 9, and 12 months, as described in the associated research study [1]. Ossabaw swine on atherogenic diet had increased body weight, hypertension, and dyslipidemia, compared to lean controls (Table 1).
Table 1.
Lean | MetS (6 months) | MetS (9 months) | MetS (12 months) | Significance | |
---|---|---|---|---|---|
Body weight (kg) | 62±5 | 89±2 | 87±7 | 116±2 | 12>9, 6>lean |
Fasting blood glucose (mg/dL) | 84±6 | 75±2 | 82±7 | 81±2 | NS |
Systolic blood pressure (mmHg) | 131±7 | 150±9 | 143±4 | 170±7 | 12, 9, 6>lean |
Diastolic blood pressure (mmHg) | 63±2 | 77±5 | 85±4 | 89±5 | 12, 9>6, lean |
Total cholesterol (mg/dL) | 57±5 | 383±39 | 546±66 | 247±17 | 9>12, 6>lean |
Triglycerides (mg/dL) | 25±4 | 34±4 | 98±34 | 43±6 | 9>12, 6, lean |
NS=not significant.
2. Experimental design, materials and methods
2.1. Animal care
All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee at Indiana University School of Medicine with the recommendations outlined by the National Research Council and the American Veterinary Medical Association Panel on Euthanasia [2,3]. Six month old Ossabaw miniature swine were fed 1 kg of an excess-calorie atherogenic diet (KT-324, Purina Test Diet, Richmond, IN; 16% kcal from protein, 41% kcal from complex carbohydrates, 19% kcal from fructose, and 43% kcal from fat). The feed was supplemented with cholesterol (2.0%), hydrogenated coconut oil (4.70%), hydrogenated soybean oil (8.40%), cholate (0.70%), and high fructose corn syrup (5.0%) by weight [6], [7], [8], [5], [4] daily for 6 (n=6), 9 (n=7), or 12 (n=9) months. Lean control swine (n=9) were fed 725 g of a standard diet (5L80, Purina Test Diet, Richmond, IN; 18% kcal from protein, 71% kcal from complex carbohydrates, and 11% kcal from fat). Swine were housed individually with free access to drinking water and on a 12 h light/dark cycle.
2.2. Metabolic phenotyping
Final body weights and blood were obtained at time of sacrifice. Plasma was obtained from heparinized whole blood by centrifugation at 2000 rpm for 20 min. Lipid and glucose biochemistry was performed by ANTECH Diagnostics (Fishers, IN).
2.3. Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 (San Diego, CA). One-way analysis of variance (ANOVA) with Bonferroni post hoc analysis was performed. Data are represented as mean±SEM. p<0.05 was considered significant.
Acknowledgements
The authors wish to acknowledge James P. Byrd, Josh Sturek, and Brandy Sparks for wonderful technical support during the metabolic phenotyping phase of this study. This study was supported by National Institutes of Health (HL-062552 and T32DK064466), American Heart Association (15PRE25280001), Indiana CTSI Predoctoral TL1 Training Fellowship (TR000162), the Fortune-Fry Ultrasound Research Fund, and the Cardiometabolic Disease Research Foundation.
Footnotes
Supplementary data associated with this article can be found in the online version at doi:10.1016/j.dib.2016.04.023.
Appendix A. Supplementary material
References
- 1.McKenney-Drake M.L., Rodenbeck S.D., Owen M.K., Schultz K.A., Alloosh M., Tune J.D., Sturek M. Biphasic alterations in coronary smooth muscle Ca2+regulation during coronary artery disease progression in metabolic syndrome. Atherosclerosis. 2016 doi: 10.1016/j.atherosclerosis.2016.03.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Institute for Laboratory Animal Research . Guide for the Care and Use of Laboratory Animals. National Academy Press; Washington, DC: 2010. [Google Scholar]
- 3.AVMA Panel on Euthanasia, American Veterinary Medical Association, 2000 Report of the AVMA panel on euthanasia, JAVMA 218 (2001) 669-696. [DOI] [PubMed]
- 4.Neeb Z.P., Edwards J.M., Alloosh M., Long X., Mokelke E.A., Sturek M. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp. Med. 2010;60:300–315. [PMC free article] [PubMed] [Google Scholar]
- 5.Wang H.W., Langohr I.M., Sturek M., Cheng J.X. Imaging and quantitative analysis of atherosclerotic lesions by CARS-based multimodal nonlinear optical microscopy. Arterioscler. Thromb. Vasc. Biol. 2009;29:1342–1348. doi: 10.1161/ATVBAHA.109.189316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Edwards J.M., Neeb Z.P., Alloosh M.A., Long X., Bratz I.N., Peller C.R., Byrd J.P., Kumar S., Obukhov A.G., Sturek M. Exercise training decreases store-operated Ca2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc. Res. 2010;85:631–640. doi: 10.1093/cvr/cvp308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sturek M., Alloosh M., Wenzel J., Byrd J.P., Edwards J.M., Lloyd P.G., Tune J.D., March K.L., Miller M.A., Mokelke E.A., Brisbin I.L., Jr. Ossabaw Island miniature swine: cardiometabolic syndrome assessment. In: Swindle M.M., editor. Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques. CRC Press; Boca Raton: 2007. pp. 397–402. [Google Scholar]
- 8.Kreutz R.P., Alloosh M., Mansour K., Neeb Z.P., Kreutz Y., Flockhart D.A., Sturek M. Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity. Diabetes Metab. Syndr. Obes.: Targets Ther. 2011;4:99–105. doi: 10.2147/DMSO.S17105. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.